US Stock MarketDetailed Quotes
SRTOY SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS
- 19.650
- 0.0000.00%
15min DelayClose Dec 18 16:00 ET
19.12BMarket Cap112.93P/E (TTM)
0.000High0.000Low19Volume18.910Open19.650Pre Close0.00Turnover0.00%Turnover Ratio56.47P/E (Static)972.92MShares29.50052wk High4.67P/B19.12BFloat Cap15.75052wk Low0.08Dividend TTM972.92MShs Float29.500Historical High0.39%Div YieldTTM0.00%Amplitude15.750Historical Low0.000Avg Price1Lot Size
SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.72%655.4M | 4.54%706.4M | -20.53%2.78B | -20.58%706.8M | -24.08%666.9M | -21.59%675.7M | -15.81%726.1M | 20.98%3.49B | 14.37%890M | 16.04%878.4M |
| Operating revenue | -1.72%655.4M | 4.54%706.4M | -20.53%2.78B | -20.58%706.8M | -24.08%666.9M | -21.59%675.7M | -15.81%726.1M | 20.98%3.49B | 14.37%890M | 16.04%878.4M |
| Cost of revenue | -2.91%380M | 7.27%400.1M | -7.96%1.54B | -5.14%411.8M | -6.23%391.4M | -10.31%373M | -13.80%351.6M | 25.59%1.68B | 15.95%434.1M | 20.74%417.4M |
| Gross profit | -0.04%275.5M | 1.16%306.2M | -32.13%1.23B | -35.31%295M | -40.22%275.6M | -32.11%302.7M | -17.60%374.5M | 17.03%1.82B | 12.93%456M | 12.08%461M |
| Operating expense | 9.58%204.7M | 6.38%201.9M | 0.08%763M | 3.45%179.9M | -9.58%186.8M | 0.64%189.8M | 14.23%220.8M | 13.79%762.4M | 3.14%173.9M | 14.91%206.6M |
| Selling and administrative expenses | 3.32%155.7M | 7.69%158.3M | 0.70%616.2M | 1.29%165.1M | -2.52%150.7M | 2.37%147M | 1.46%152.8M | 15.08%611.9M | 4.49%163M | 22.31%154.6M |
| -Selling and marketing expense | 6.86%118.4M | 6.92%118.9M | -0.13%449.1M | -3.87%111.7M | -4.24%110.8M | 2.87%111.2M | 5.10%115.3M | 10.87%449.7M | 0.96%116.2M | 14.10%115.7M |
| -General and administrative expense | -6.52%37.3M | 10.06%39.4M | 3.02%167.1M | 14.10%53.4M | 2.57%39.9M | 0.85%35.8M | -8.31%37.5M | 28.63%162.2M | 14.43%46.8M | 55.60%38.9M |
| Research and development costs | 30.88%37.3M | 18.92%35.2M | -2.19%129.5M | -6.49%36M | -1.38%28.5M | -6.62%29.6M | 6.31%35.4M | 19.82%132.4M | 23.40%38.5M | 6.64%28.9M |
| Other operating expenses | 20.56%21.7M | -29.90%14.3M | -7.77%26.1M | 49.22%-39.1M | -61.78%18M | -37.80%20.4M | 246.81%32.6M | -11.01%28.3M | -427.40%-77M | 79.09%47.1M |
| Operating profit | -20.27%70.8M | -7.62%104.3M | -55.40%470.5M | -59.20%115.1M | -65.09%88.8M | -56.12%112.9M | -41.16%153.7M | 19.48%1.06B | 19.94%282.1M | 9.89%254.4M |
| Net non-operating interest income expense | 14.73%-35.3M | -184.38%-38.9M | -1,163.92%-122.6M | 3.10%-122.1M | -397.84%-41.4M | 77.99%46.1M | -106.67%-5.1M | -44.78%-9.7M | -415.00%-126M | 168.81%13.9M |
| Non-operating interest income | --2.6M | -82.44%12.8M | 1,140.00%6.2M | 55.61%-71.2M | ---- | 95.97%72.9M | -82.51%15.3M | 66.67%500K | -955.26%-160.4M | 828.21%36.2M |
| Non-operating interest expense | -8.45%37.9M | 92.91%51.7M | 529.03%117M | 250.38%39.1M | 85.65%41.4M | 137.17%26.8M | 85.45%20.4M | 78.85%18.6M | 49.81%-26M | -7.47%22.3M |
| Total other finance cost | ---- | ---- | 240.48%11.8M | ---- | ---- | ---- | ---- | -147.06%-8.4M | ---- | ---- |
| Other net income (expense) | ||||||||||
| Special income (charges) | ---- | ---- | -54.54%59.6M | ---- | ---- | ---- | ---- | 154.90%131.1M | ---- | ---- |
| -Less：Restructuring and merger&acquisition | ---- | ---- | 50.27%-74.4M | ---- | ---- | ---- | ---- | -170.47%-149.6M | ---- | ---- |
| -Less:Other special charges | ---- | ---- | -20.00%14.8M | ---- | ---- | ---- | ---- | -30.19%18.5M | ---- | ---- |
| Income before tax | -24.95%35.5M | -58.84%65.4M | -64.52%401.1M | -80.80%46.3M | -82.37%47.3M | -43.89%158.9M | -56.01%148.6M | 74.80%1.13B | 428.73%241.1M | 26.98%268.3M |
| Income tax | -25.20%9.2M | -34.88%16.8M | -64.47%89M | -71.01%13.8M | -81.67%12.3M | -62.34%25.8M | -44.96%37.1M | 7.79%250.5M | -14.85%47.6M | 5.67%67.1M |
| Net income | -24.86%26.3M | -63.49%48.6M | -64.53%312.1M | -83.20%32.5M | -82.60%35M | -38.01%133.1M | -58.82%111.4M | 112.38%879.9M | 1,978.64%193.5M | 36.13%201.2M |
| Net income continuous Operations | -24.86%26.3M | -63.49%48.6M | -64.53%312.1M | -83.20%32.5M | -82.60%35M | -38.01%133.1M | -58.76%111.5M | 112.38%879.9M | 1,978.64%193.5M | 36.13%201.2M |
| Minority interest income | 33.33%800K | 1M | -36.84%2.4M | -53.33%1.4M | 0.00%600K | 0 | 33.33%400K | 3,900.00%3.8M | 287.50%3M | 160.00%600K |
| Net income attributable to the parent company | -25.87%25.5M | -64.24%47.6M | -64.65%309.7M | -83.67%31.1M | -82.85%34.4M | -38.04%133.1M | -58.88%111.1M | 111.41%876.1M | 2,289.66%190.5M | 34.81%200.6M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -25.87%25.5M | -64.24%47.6M | -64.65%309.7M | -83.67%31.1M | -82.85%34.4M | -38.04%133.1M | -58.88%111.1M | 111.41%876.1M | 2,289.66%190.5M | 34.81%200.6M |
| Basic earnings per share | -29.73%0.026 | -65.28%0.05 | -64.67%0.336 | -83.57%0.034 | -83.03%0.037 | -38.20%0.144 | -58.70%0.121 | 111.33%0.951 | 2,400.00%0.207 | 35.40%0.218 |
| Diluted earnings per share | -29.73%0.026 | -65.28%0.05 | -64.67%0.336 | -83.57%0.034 | -83.03%0.037 | -38.20%0.144 | -58.70%0.121 | 111.33%0.951 | 2,400.00%0.207 | 35.40%0.218 |
| Dividend per share | 0 | 0 | 15.66%0.1434 | 0 | 0 | 0 | 15.66%0.1434 | 83.87%0.124 | 0 | 0 |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Heat List
US
Overall
Symbol
Price
% Chg
No Data